Laura McAllister

Monte Rosa Therapeutics

Poster(s):

• W135 - MRT-6160, a VAV1-Directed Molecular Glue Degrader, Inhibits Disease Progression in a Preclinical Model of T/B-cell-Mediated Experimental Autoimmune Encephalomyelitis
  Wednesday, June 25, 2025

  7:30am - 7:30pm East Coast USA Time